Loading...
XWAR
BMX
Market cap10mUSD
Jul 09, Last price  
9.30PLN
1D
-0.53%
1Q
-21.05%
Jan 2017
92.15%
IPO
17.72%
Name

BioMaxima SA

Chart & Performance

D1W1MN
XWAR:BMX chart
P/E
371.39
P/S
0.64
EPS
0.03
Div Yield, %
Shrs. gr., 5y
-0.46%
Rev. gr., 5y
-0.23%
Revenues
61m
+15.24%
6,669,4287,163,84610,491,70518,818,62020,965,51020,440,95521,965,26026,984,19831,574,52630,817,69230,487,87061,609,50879,088,000143,867,00046,786,00052,851,00060,904,000
Net income
105k
-80.37%
610,366539,042998,9531,375,0641,320,371454,8331,454,7471,227,716805,6830-13,5067,949,00010,243,00028,885,000586,000535,000105,000
CFO
2m
P
418,323102,8851,832,45101,249,426561,0162,286,8831,439,1421,839,4002,120,2564,927,7823,972,697-132,00037,065,0001,592,000-152,0002,336,000
Dividend
Jun 16, 20230.5 PLN/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

BioMaxima S.A. produces and distributes microbiological media, reagents, and in vitro diagnostic equipment in Poland. It offers microbiology products, including ready to use media, such as plates, bottles, bags, and media in tubes; dehydrated media; agars and peptones; and supplements. The company also provides molecular biology and cell culture products which includes real time PCR, nucleic acid isolation, NA and PCR electrophoresis, protein electrophoresis, enzymes, antibiotics, agaroses and molecular biology media, media and buffers for in vitro cultures, phenotypic micromatrices, plastics and small equipment, basic substrate components, and form. In addition, it offers laboratory diagnostics solutions for various areas of clinical chemistry, haematology, coagulology, immunochemistry, POCT, rapid tests, and blood collection systems; and disposable materials comprising microbiology, dispensing equipment, tubes, plugs, tripods, capillaries, equipment, aspiration-vacuum system, containers, tank for analysers, urine analysis, microscope slides, reagent tubes, autoclave equipment, and pliers and scissors. BioMaxima S.A. was founded in 1997 and is headquartered in Lublin, Poland.
IPO date
Jun 08, 2010
Employees
122
Domiciled in
PL
Incorporated in
PL

Valuation

Title
PLN in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT